Novo Nordisk selects ‘local presence’ for Asia-Pacific distribution

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/ Local Images)
(Image: Getty/ Local Images)

Related tags: Asia pacific, Asia, API, compound, distribution agreement, Pharmaceutical companies, Novo Nordisk Pharmatech, Novo nordisk

Novo Nordisk Pharmatech selected DKSH to distribute its pharmaceutical grade compounds to the company’s growing customer base in the Asia-Pacific region.

DKSH, an ingredients and chemicals distributor, was chosen for Novo Nordisk’s pharmaceutical grade compounds (quats) due to its logistical infrastructure and experience in the region.

Steve Profit, global sales and marketing director at Novo Nordisk Pharmatech, told us, “South East Asia is a fast-growing market with massive expansion happening within existing customers’ sites plus new business ventures in exciting new high growth regions.”

“To ensure that our customers worldwide get the best partner for key supplies possible, we wanted a partner with not only a local presence and excellent service but one that had a shared vision towards business ethics and product expertise to deliver excellence to our customers.”

DKSH is located within the region with an “omni-channel approach” ​for a “one-stop regional solution”​ for its clients. Profit explained that Asia-Pacific is the third largest pharmaceutical market in the world. He added that, in the region, “pharma sales will grow 8.4% by 2021.”

The quats include benzalkonium chloride, cetrimonium bromide, and cetrimide.

In a statement Tanja Schaffer, vice president, global pharmaceutical industry, DKSH, said that the quats it will be distributing are a “perfect fit”​ for its active pharmaceutical ingredients portfolio.

Related news

Show more

Related products

show more

Integrated Solutions for Accelerated Time to Market

Integrated Solutions for Accelerated Time to Market

Piramal Pharma Solutions | 08-Jun-2021 | Technical / White Paper

Facing capacity constraints? Lock in your program now! With 14 sites around the world providing diverse services ranging from discovery to drug substance...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

Related suppliers

Follow us


View more